机构:[1]Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[2]Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Kunming Medical University, Kunming, China外科科室妇产科产科妇科昆明医科大学附属第一医院[3]Department of Gynaecology and Obstetrics, The Third People’s Hospital of Kunming, Kunming, China[4]Department of Infectious Disease, The Third People’s Hospital of Kunming, Kunming, China[5]International Agency for Research on Cancer, Lyon, France
This study was financially supported by National Natural Science
Foundation of China (81761128006), Chinese Academy of Medical Sciences
Initiative for Innovative Medicine (2016-I2M-
1–019), China Medical Board (16-255),
and National Key R&D Program of China (2018YFC1315504).
第一作者机构:[1]Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
通讯作者:
通讯机构:[1]Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[*1]National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
Duan Rufei,Zhang Hongyun,Wu Aihui,et al.Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China.[J].SEXUALLY TRANSMITTED INFECTIONS.2022,98(4):247-254.doi:10.1136/sextrans-2021-055019.
APA:
Duan Rufei,Zhang Hongyun,Wu Aihui,Li Chongxi,Li Le...&Clifford Gary.(2022).Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China..SEXUALLY TRANSMITTED INFECTIONS,98,(4)
MLA:
Duan Rufei,et al."Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China.".SEXUALLY TRANSMITTED INFECTIONS 98..4(2022):247-254